Citadel Advisors
SXTPW icon

Citadel Advisors’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Citadel Advisors’s Portfolio SXTPW Stock Details SXTPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,400
Closed -$621 – 14814
2026
Q1 		$621 Sell
12,400
-3,174
-20% -$204 ﹤0.01% 12843
2025
Q4 		$978 Sell
15,574
-5,221
-25% -$255 ﹤0.01% 12489
2025
Q3 		$769 Buy
20,795
+3,127
+18% +$215 ﹤0.01% 12604
2025
Q2 		$783 Sell
17,668
-24,754
-58% -$1.28K ﹤0.01% 12274
2025
Q1 		$976 Sell
42,422
-5,253
-11% -$145 ﹤0.01% 14190
2024
Q4 		$1.71K Buy
47,675
+1,402
+3% +$41 ﹤0.01% 14153
2024
Q3 		$2.79K Buy
46,273
+7,231
+19% +$417 ﹤0.01% 13718
2024
Q2 		$2.74K Buy
39,042
+11,527
+42% +$1.07K ﹤0.01% 13656
2024
Q1 		$4.13K Buy
+27,515
New +$2.2K ﹤0.01% 13836

Other funds holding SXTPW

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's SXTPW Position: Q2 2026 in Review

Citadel Advisors sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q2 2026, closing a stake of 12,400 shares — an estimated $621 sold.

Citadel Advisors first reported a position in SXTPW in Q1 2024 and held it in 9 quarters. The position peaked at $4.13K in Q1 2024. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2026.

  • Citadel Advisors reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 12,400 60 Degrees Pharmaceuticals Warrant shares in Q2 2026, an estimated $621.
  • Citadel Advisors first reported a position in 60 Degrees Pharmaceuticals Warrant in Q1 2024 and held it in 9 quarters.
  • Citadel Advisors's 60 Degrees Pharmaceuticals Warrant position peaked at $4.13K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.